OCUP: Ocuphire Pharma Inc. Stocks News on July 5, 2024

OCUP

GlobeNewswire

a month ago

Ocuphire Pharma Announces Presentations on the Development of APX3330 for Diabetic Retinopathy at Retina Meetings in June

OCUP

Simply Wall St.

2 months ago

Ocuphire Pharma First Quarter 2024 Earnings: Misses Expectations

OCUP

GlobeNewswire

2 months ago

Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update

OCUP

GlobeNewswire

2 months ago

Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting

OCUP

GlobeNewswire

2 months ago

Ocuphire Pharma to Present at the Aegis Virtual Conference

OCUP

GlobeNewswire

2 months ago

Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting

$First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery$

OCUP

GlobeNewswire

3 months ago

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery

OCUP

GlobeNewswire

3 months ago

Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris

OCUP

Simply Wall St.

4 months ago

Earnings Update: Ocuphire Pharma, Inc. (NASDAQ:OCUP) Just Reported And Analysts Are Trimming Their Forecasts

OCUP

Simply Wall St.

4 months ago

Ocuphire Pharma Full Year 2023 Earnings: Misses Expectations

OCUP

GlobeNewswire

4 months ago

Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update

OCUP

GlobeNewswire

4 months ago

Ocuphire Pharma to Present in the BIO CEO & Investor Conference

OCUP

GlobeNewswire

5 months ago

Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

OCUP

GlobeNewswire

5 months ago

Ocuphire Pharma Strengthens Leadership Team with Key Appointments

OCUP

GlobeNewswire

5 months ago

Ocuphire Pharma Announces Presentation on APX3330 at the Annual Angiogenesis, Exudation, and Degeneration 2024 Conference

OCUP

Motley Fool

5 months ago

Why Fisker Stock Shot Higher Today

With the S&P 500 at a record high, strategists warn against a valuation 'trap'

OCUP

Yahoo Finance

5 months ago

With the S&P 500 at a record high, strategists warn against a valuation 'trap'

OCUP

GlobeNewswire

5 months ago

Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Merck-Harpoon deal, Twilio, Crocs: Trending Tickers

OCUP

Yahoo Finance Video

6 months ago

Merck-Harpoon deal, Twilio, Crocs: Trending Tickers

New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program

OCUP

Business Wire

6 months ago

New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program

Novo Nordisk, The Weight-Loss Kingpin, Breaks Out After Inking Two New Deals In Obesity

OCUP

Investor's Business Daily

6 months ago

Novo Nordisk, The Weight-Loss Kingpin, Breaks Out After Inking Two New Deals In Obesity

OCUP

GlobeNewswire

6 months ago

Ocuphire Pharma Receives FDA Agreement Under Special Protocol Assessment for LYNX-2 Phase 3 Trial of Phentolamine Ophthalmic Solution for the Treatment of Decreased Visual Acuity under Dim (mesopic) Light Conditions

AlphaTime Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders

OCUP

GlobeNewswire

6 months ago

AlphaTime Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders

Can Mixed Fundamentals Have A Negative Impact on AstroNova, Inc. (NASDAQ:ALOT) Current Share Price Momentum?

OCUP

Simply Wall St.

6 months ago

Can Mixed Fundamentals Have A Negative Impact on AstroNova, Inc. (NASDAQ:ALOT) Current Share Price Momentum?

Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer

OCUP

PR Newswire

7 months ago

Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer

inTEST Corporation Launches Next Generation of Induction Heating Systems

OCUP

Business Wire

7 months ago

inTEST Corporation Launches Next Generation of Induction Heating Systems

Adaptimmune Completes Submission of Rolling Biologics License Application (BLA) to U.S. FDA for Afami-cel for the Treatment of Advanced Synovial Sarcoma

OCUP

Newsfile

7 months ago

Adaptimmune Completes Submission of Rolling Biologics License Application (BLA) to U.S. FDA for Afami-cel for the Treatment of Advanced Synovial Sarcoma

OCUP

Business Wire

7 months ago

Certain Morgan Stanley Closed-End Funds Declare Year-End Dividends

Hedge funds investors have a lot riding on International Tower Hill Mines Ltd. (TSE:ITH) with 32% ownership

OCUP

Simply Wall St.

7 months ago

Hedge funds investors have a lot riding on International Tower Hill Mines Ltd. (TSE:ITH) with 32% ownership

OCUP

GlobeNewswire

7 months ago

Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIII

inTEST Corporation to Participate in the 12th Annual NYC Summit

OCUP

Business Wire

7 months ago

inTEST Corporation to Participate in the 12th Annual NYC Summit

OCUP

GlobeNewswire

7 months ago

Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OCUP

GlobeNewswire

7 months ago

Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer

Several Insiders Invested In California BanCorp Flagging Positive News

OCUP

Simply Wall St.

7 months ago

Several Insiders Invested In California BanCorp Flagging Positive News

EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference

OCUP

GlobeNewswire

8 months ago

EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference

Investing in Byrna Technologies (NASDAQ:BYRN) five years ago would have delivered you a 225% gain

OCUP

Simply Wall St.

8 months ago

Investing in Byrna Technologies (NASDAQ:BYRN) five years ago would have delivered you a 225% gain

OCUP

GlobeNewswire

8 months ago

Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update

OCUP

Simply Wall St.

8 months ago

Declining Stock and Solid Fundamentals: Is The Market Wrong About Ocuphire Pharma, Inc. (NASDAQ:OCUP)?

SWK Holdings Corporation to Report Third Quarter 2023 Financial Results

OCUP

PR Newswire

8 months ago

SWK Holdings Corporation to Report Third Quarter 2023 Financial Results

OCUP

Thomson Reuters StreetEvents

8 months ago

Latest Ocuphire Pharma Inc. (OCUP) News on July 5, 2024

Share on Social Networks: